new cancer cases could be diagnosed every year by 2030 according to the World Health Organization.
With the number of new cancer cases per year expected to exceed 23 million worldwide by 2030, cancer remains
one of the world's most pressing health care challenges due to the costs involved. And this
problem will be exacerbated by an aging and growing population worldwide, with more cancer patients seeking
treatment in the future.
Individualized therapies, the focal point of Pointellis™, can dramatically improve patient outcomes and
alleviate the burden of cancer and mutation-based diseases. However, the approach to health care and therapy
delivery will need to be restructured to create highly reliable, fail-safe delivery of individualized
therapies at scale.